Bath & Body Works Exceeds Q4 Guidance, Outlines 2026 Outlook Amidst Major Transformation

Key Financial Highlights for Investors

• Q4 2025 Net Sales: \$2.7 billion, down 2% year-over-year but above company guidance.
• Q4 2025 Earnings Per Diluted Share (EPS): \$1.99 (reported); \$2.05 (adjusted).
• Full-Year 2025 Net Sales: \$7.29 billion, a slight decrease of 0.2% from FY2024.
• Full-Year 2025 EPS: \$3.11 (reported); \$3.21 (adjusted), compared to \$3.61 (reported) and \$3.29 (adjusted) in FY2024.
• Net Income: \$649 million for FY2025, down from \$798 million in FY2024 (adjusted net income: \$669 million vs. \$729 million).
• Operating Income: \$1.126 billion for FY2025, down from \$1.266 billion (adjusted: \$1.156 billion vs. \$1.266 billion).
• Share Repurchases: 15.1 million shares, totaling \$400 million in FY2025.
• Cash Position: \$953 million as of January 31, 2026, up from \$674 million a year earlier.

Notable Business Developments and Transformation Activities

• Transformation Initiatives: CEO Daniel Heaf highlighted the “Consumer First Formula,” launched in Q3 2025, accelerating innovation, brand modernization, distribution expansion, and operating model simplification.
• Amazon Launch: Early rollout on Amazon and a new brand identity are cited as examples of the company’s execution and urgency.
• Business Transformation Costs: \$15 million pre-tax (\$12 million after tax) in Q4 2025, mainly related to severance; similar costs of \$15 million in Q2 related to leadership transitions.
• Asset Sales: \$8 million pre-tax gain from sale of a non-core asset in Q3 2025. In FY2024, a \$39 million pre-tax gain from Easton investments and a \$44 million tax benefit from deferred tax assets were recorded.

2026 Outlook and Guidance—What Investors Need to Know

• Net Sales Guidance: FY2026 net sales expected to decline 4.5% to 2.5% from FY2025 (\$7.29 billion base).
• EPS Guidance: FY2026 EPS forecasted at \$3.00 to \$3.25 (reported), and \$2.40 to \$2.65 (adjusted). This is a notable decrease from the FY2025 adjusted EPS of \$3.21.
• First Quarter FY2026: Net sales to decline 6% to 4% versus Q1 2025 (\$1.42 billion base). EPS expected at \$0.84 to \$0.90 (reported), and \$0.24 to \$0.30 (adjusted), a significant drop from \$0.49 in Q1 2025.
• Free Cash Flow: FY2026 expected at approximately \$600 million (operating cash of \$870 million, capex of \$270 million).
• Special Items (2026):
  • \$88 million pre-tax gain (\$65 million after tax) from settlement of payment card interchange fee litigation.
  • \$62 million tax benefit related to certain tax matters.
  • \$9 million pre-tax loss (\$7 million after tax) from anticipated early redemption of January 2027 bonds.
• No Share Repurchases Assumed: FY2026 guidance does not include any share repurchases.
• Debt Management: Outlook includes interest savings from redeeming the remaining \$284 million of January 2027 bonds.

Operational and Segment Details

• Store Count: 1,927 company-operated stores in the U.S. and Canada (net increase of 32 during FY2025); 573 partner-operated international stores (net increase of 44).
• Sales Channel Performance:
  • U.S. and Canada Stores: Q4 sales down 2.6% (to \$2.05 billion); FY2025 up 0.9% (to \$5.58 billion).
  • Direct (Online): Q4 sales down 2.5% (to \$579 million); FY2025 down 5.4% (to \$1.395 billion).
  • International: Q4 sales up 8.6% (to \$91 million); FY2025 up 4.9% (to \$314 million).

Shareholder-Relevant and Price-Sensitive Information

• Declining Sales and EPS Guidance for 2026: Both top-line and bottom-line are expected to contract in FY2026, which may be seen as negative by the market.
• Transformation Costs and Gains: Ongoing transformation expenses and special gains/losses are impacting reported results, and these non-core items should be carefully considered by investors when evaluating the company’s recurring earnings power.
• Cash Generation Remains Strong: Despite expected sales and earnings declines, Bath & Body Works anticipates robust free cash flow, supporting potential future investments or shareholder returns beyond FY2026.
• No Share Repurchases in 2026: This is a change from FY2025 and may impact EPS growth and investor sentiment.
• Ongoing Transformation: The company is repositioning from a specialty retailer to a “premier global brand,” a process that introduces execution risk but also long-term growth opportunity if successful.

Additional Information

• Investors are encouraged to follow company updates on the investor relations website and social media channels, as material information may be disclosed via these platforms.

Conclusion

Bath & Body Works delivered better-than-expected Q4 earnings and is making progress on its transformation plan, but the company is guiding for lower sales and earnings in FY2026. Significant special items and the absence of buybacks are important for shareholders to note. The ongoing business transformation, execution of its Consumer First Formula, and ability to manage costs and capitalize on new channels (like Amazon) will be closely watched by the market and could be key drivers of future share price performance.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. The author and publisher are not responsible for any losses that may result from reliance on the information contained herein.

View Bath & Body Works, Inc. Historical chart here